China Health Industries Holdings, Inc.
chinahealthindustries.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2024 10-Q, filed Jun 26, 2024. Its latest SEC filing is a NT 10-Q from Feb 14, 2025.
10-Q for Q3 FY2024, filed Jun 26, 2024
The sections below describe the company as of the FY2023 annual report.
What Did They Do?
Sells hemp-derived products to Chinese consumers through sales agents, alongside medicines and health supplements.
10-K for FY2023, filed Nov 13, 2023The Company owns a GMP-certified plant and production facilities and has the capacity to produce 21 different NMPA-approved medicines, 14…View ↗
HLJ Huimeijia was founded on October 30, 2003 and its latest GMP certificate is effective until April 24, 2023. On December 1, 2019, NMPA…View ↗
We have developed the following products that are derived from hemp and obtained business license to manufacture and sell these products.…View ↗
We sell most of our products to sales agents, who are our customers. The sales agents sell the products to the end users.View ↗
How Did They Make Money?
Customers buy the company's products, and the company becomes entitled to payment when the products ship.
10-K for FY2023, filed Nov 13, 2023Revenue RecognitionView ↗
$111.6K
-
10-K for FY2023, filed Nov 13, 2023
$111.6K ↗
Who Were Their Customers?
It sells most products to sales agents, who resell them to end users; its own sales staff also sells directly to end customers, mainly in Heilongjiang Province.
10-K for FY2023, filed Nov 13, 2023
10-K for FY2023, filed Nov 13, 2023
For the year ended June 30, 2023, the Company had three customers that in aggregate accounted for 100% of the Company’s total sales, with…View ↗
Did Revenues Turn Into Profits?
No. It lost $408.8K in FY2023.
10-K for FY2023, filed Nov 13, 2023
How Were They Changing?
- Net income
-
Sources
10-Q for Q3 FY2024, filed Jun 26, 2024
−$142.8KView ↗
- ▼ −51% (Loss)
- vs −$290.3K in Q3 FY2023
-
Sep 13, 2024
Company replaced its independent auditor
The board dismissed Assentsure and engaged GGF CPA LTD as the new independent auditor.
Sources
8-K, filed Sep 13, 2024
On September 12, 2024, the Board of Directors of China Health Industries Holdings, Inc., a corporation incorporated under the laws of the…View ↗
-
Jul 17, 2024
Company completed the sale of Humankind
China Health HK transferred all equity interests in Humankind to Xin Sun and Liyuan Sun.
Sources
8-K, filed Jul 17, 2024
On July 8, 2024, China Health HK entered into certain stock transfer agreements (collectively, the “Agreements”) with Mr. Xin Sun and Ms.…View ↗
-
Dec 4, 2023
Company completed its acquisition of HempCan
The company paid the sellers for all equity in HempCan, and the ownership registration was completed.
Sources
8-K, filed Dec 4, 2023
On December 1, 2023, the Company closed the Acquisition. The transfer of the equity interests of Heilongjiang HempCan Pharmaceuticals Co.…View ↗
Hemp product sales
The earlier report highlighted hemp oil, protein powder and polypeptide; the latest report describes sales of new hemp seed beer and raw hemp seed.
10-K for FY2020, filed Oct 13, 2020 10-K for FY2023, filed Nov 13, 2023We have developed the following products that are derived from hemp and obtained business license to manufacture and sell these products.…View ↗
Total revenues of the Company increased by $111,312 or 41,689.9%, for the year ended June 30, 2023 as compared to the year ended June 30…View ↗
Who Did They Compete With?
Competes with Harbin DaZhong Pharmaceutical, Tsinghua Unisplendour, Heilongjiang Tianlong Pharmaceuticals, HPGC Renmintongtai Pharmaceuticals, and Yunnan Hansu Biotechnology
10-K for FY2023, filed Nov 13, 2023Harbin DaZhong Pharmaceutical Co., Ltd. (Located in Harbin, Heilongjiang Province);View ↗
Loading...
